Gland Pharma Fundamentals
P/E Ratio
31.61
P/B Ratio
2.73
Div. Yield
1.11
Sector P/E
60
Sector P/B
2.63
Sec. Div. Yield
0.59
Gland Pharma Fundamentals is currently trading with a P/E Ratio of 31.61, compared to the sector average of 60. Its P/B Ratio stands at 2.73, while the sector’s is 2.63. In terms of returns, the stock offers a Dividend Yield of 1.11%, which is than the sector’s 0.59%.
Gland Pharma Score Card
Price
Attractive
Growth
Moderate
Quality
Good
Management
Good
On its scorecard, Gland Pharma reflects: Price – Attractive, Growth – Moderate, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
